Likewise, Wang and collaborators recently described rs323085 in the OR52B4 gene being associated with good anti-VEGF therapy responses, whereas rs4910623 and rs10158937 in the OR52B4 gene were associated with poor anti-VEGF therapy responses in AMD patients. Here, VEGFA is linked to age-related macular degeneration.